MMP inhibition blocks fibroblast-dependent skin cancer invasion, reduces vascularization and alters VEGF-A and PDGF-BB expression

Anticancer Res. 2010 Mar;30(3):703-11.

Abstract

Tumor invasion requires intense interactions with stromal cells and a profound extracellular matrix remodelling by matrix metalloproteinases (MMPs). Here, we assessed the specific contribution of fibroblasts to tumor invasion, MMPs, tissue inhibitors of MMPs and angiogenesis-related cytokine expression in organotypic cultures of highly malignant HaCaT-ras A-5RT3 cells, with and without MMP inhibition. Collagen degradation, the hallmark of tumor invasion, was dependent on fibroblasts and active MMP-2. Additionally, MMP blockade down-regulated VEGF-A and up-regulated PDGF-BB. These results were paralleled in xenotransplants in vivo, demonstrating strong inhibitory effects of MMP blockade on tumor invasion and vascularization, as shown by the almost complete absence of VEGF-A and MMP-14 and by the decrease in relative blood volume. MMP blockade also increased the fraction of mature vessels, as demonstrated by an increased mean tumor vessel diameter and a higher ratio of Ng2-positive vessels. Thus, this study highlights the importance of targeting the tumor stroma to defeat cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Becaplermin
  • Carcinoma, Squamous Cell / blood supply
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology
  • Cell Line, Tumor
  • Collagen / metabolism
  • Fibroblasts / enzymology
  • Fibroblasts / pathology
  • Humans
  • Matrix Metalloproteinases, Secreted / antagonists & inhibitors*
  • Matrix Metalloproteinases, Secreted / biosynthesis
  • Matrix Metalloproteinases, Secreted / metabolism
  • Mice
  • Mice, Nude
  • Neoplasm Invasiveness
  • Organic Chemicals / pharmacology
  • Piperazines / pharmacology
  • Platelet-Derived Growth Factor / biosynthesis*
  • Proto-Oncogene Proteins c-sis
  • Pyrimidines / pharmacology
  • Skin Neoplasms / blood supply
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / metabolism*
  • Skin Neoplasms / pathology
  • Tissue Inhibitor of Metalloproteinase-1 / biosynthesis
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Tissue Inhibitor of Metalloproteinase-2 / biosynthesis
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism
  • Vascular Endothelial Growth Factor A / biosynthesis*
  • Xenograft Model Antitumor Assays

Substances

  • Organic Chemicals
  • Piperazines
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Pyrimidines
  • Ro 28-2653
  • Tissue Inhibitor of Metalloproteinase-1
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • prinomastat
  • Tissue Inhibitor of Metalloproteinase-2
  • Becaplermin
  • Collagen
  • Matrix Metalloproteinases, Secreted